Leprosy control, public health paradigms and stigma

Australian and New Zealand Journal of Public Health

Volumn 35, Issue 1, 2011, Pages 9-11

  Awofeso, Niyi ^a  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

EDITORIAL; HEALTH PROMOTION; HISTORY; HUMAN; LEPROSY; PRIMARY HEALTH CARE; PUBLIC HEALTH; SOCIAL PSYCHOLOGY; SOCIAL STIGMA;

HEALTH PROMOTION; HISTORY, 17TH CENTURY; HISTORY, 18TH CENTURY; HISTORY, 19TH CENTURY; HISTORY, 20TH CENTURY; HUMANS; LEPROSY; PRIMARY HEALTH CARE; PUBLIC HEALTH; SOCIAL STIGMA; STEREOTYPING;

EID: 79953832308     PISSN: 13260200     EISSN: 17536405     Source Type: Journal    
DOI: 10.1111/j.1753-6405.2010.00662.x     Document Type: Editorial

References (28)

1. Awofeso, N, Leper – What's in a name. Trop Doct, 23, 1993, 129.
2. Volinn, IJ, Issues of definition and their implications: AIDS and leprosy. Soc Sci Med 29 (1989), 1157–1162.
3. Shears, P, Twenty-first century lepers: an unfortunate phrase to use. J Hosp Inf, 76, 2010, 189.
4. World Health Organization. Global leprosy situation 2010. Weekly Epidemiol Record 35 (2010), 337–348.
5. Noordeen, SK, Bravo, LL, Sundaresan, TK, Estimated number of leprosy cases in the world. Bull World Health Organ 70 (1992), 7–10.
6. NNDSS Annual Report Writing Group. Australia's notifiable disease status, 2008. Annual report of the national notifiable disease surveillance system (NNDSS). Comm Dis Intell, 34, 2010, 214.
7. Awofeso, N, What's new about the “New Public Health”? Saarbrucken, 2010, Lambert Academic Publishing, Germany.
8. Jacob, JT, Franco-Paredes, C, The Stigmatization of Leprosy in India and Its Impact on Future Approaches to Elimination and Control. PLoS Negl Trop Dis. [serial on the internet], 2, 2008, e113 doi: 10.1371journal.pntd.0000113. [Cited 2010 Oct 4]. Available from: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2217676/.
9. Short, RA, The Bible and modern medicine, 1953, Paternoster Press, London, 77.
10. Gussow, Z, Leprosy, racism and public health: social policy in chronic disease control, 1989, Westview Press, Boulder.
11. Parker, R, Miasma: pollution and purification by early Greek religion, 1983, Oxford University Press, New York, 71–96.
12. Leung, AKC, Leprosy in China: a history, 2009, Colombia University Press, New York, 138.
13. Mewani R. ‘The Island of the Unclean’: Race, Colonialism and ‘Chinese Leprosy’ in British Columbia, 1891–1924. Law Social J Global Dev. (serial on the Internet) 2003. [Cited 2010 Oct 14]. Available from: http://elj.warwick.ac.uk/global/03‐1/mawani.html.
14. Kerr-Pontes, LRS, Montenegro, ACD, Werneck, MGL, Feldmeier, H, Inequality and leprosy in Northeast Brazil: an ecological study. Int J Epidemiol 33 (2004), 262–269.
15. Orgens, LM, Bjerkedel, T, Epidemiology of leprosy in Norway: the history of the national leprosy registry of Norway from 1856 until today. Int. J. Epid 2 (1973), 81–89.
16. Oppenheimer, GM, Susser, E, The Context and Challenge of von Pettenkofer's Contributions to Epidemiology. Am J Epidemiol 66 (2007), 1239–1241.
17. Cochrane, R.G., Treatment of leprosy. BMJ, 2(5202), 1960, 860.
18. Mohamed, AP, Ramanujam, K, Genetics and leprosy: a study of leprosy in twins. Lepr India 36 (1964), 77–86.
19. World Health Organization. Multidrug therapy against leprosy: development and implementation over the past 25 years, 2004, WHO, Geneva.
20. World Health Assembly. Resolution to eliminate leprosy as a public health problem by the year 2000 (resolution WHA44.9), 1991, 44th World Health Assembly, Geneva.
21. Saunderson, P, Leprosy Elimination: not as straightforward as It seemed. Public Health Rep 123 (2008), 213–216.
22. Long-term relapse risk of multibacillary leprosy after completion of 2 years of multiple drug therapy (WHO-MDT) in Cebu, Philippines. Am J Trop Med Hyg 81 (2009), 895–899.
23. Kindig, D, Stoddart, G, What is Population Health. Am J Public Health 93 (2003), 380–383.
24. Cunha SS, Alexander N, Barreto ML et al. BCG revaccination does not protect against leprosy in the Brazilian amazon: A cluster randomised trial. PLoS Negl Trop Dis. (serial on the internet) 2008 February [cited 2010 Oct 16]; 2: e167. Available from: http://www.plosntds.org/article/info%3Adoi%2F10.1371%2Fjournal.pntd.0000167.
25. Mira, MT, Alcais, A, Thuc, NV, et al. Susceptibility to leprosy is associated with PARK2 and PACRG. Nature 427 (2004), 636–640.
26. Hamilton, HK, Lewis, WR, Martiniuk, F, Cabrera, A, Wolf, J, The role of the armadillo and sooty mangabey monkey in human leprosy. Int J Dermatol 47 (2008), 545–550.
27. World Health Organization. Enhanced global strategy for further reducing the disease burden due to leprosy, 2009, WHO, New Delhi.
28. Awofeso N, Rammohan A. community arts and health advocacy in HIV/AIDS activism. Hektoen Int (serial available on Internet) 2010 [cited 2010 Oct 18]. Available from: http://www.hektoeninternational.org/kindredparadigms_AIDSadvocacy.html.